ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

ADVFN

Trade Now

EasyMarkets
Market Data
News
Tools
Markets
Discover
Subscribe Login/Register Profile Icon
S&P 500
4,604.37
(
0.41%
)
US Tech 100
15,700.80
(
0.54%
)
Dow Jones
36,247.87
(
0.36%
)
Brent Oil
75.965
(
0.0%
)
Bitcoin
43,968.79
(
-0.49%
)
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Arcutis Biotherapeutics Inc (ARQT)

  7. Arcutis Biotherapeutics Inc (ARQT) News

ARQT Arcutis Biotherapeutics Inc

2.17
-0.03 (-1.36%)
Dec 08 2023 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Arcutis Biotherapeutics Inc ARQT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
Upgrade Icon
-0.03 -1.36% 2.17 19:38:52
Open Price Low Price High Price Close Price Prev Close
2.20 2.115 2.22 2.16 2.20
more quote information »

Recent News

Date Time Source Heading
12/01/202322:00GLOBEArcutis Biotherapeutics Reports Inducement Grants Under..
12/01/202320:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/29/202315:51EDGAR2Form 144 - Report of proposed sale of securities
11/29/202308:00GLOBEFDA Accepts Arcutis’ Supplemental New Drug Application for..
11/21/202317:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/21/202315:36EDGAR2Form 144 - Report of proposed sale of securities
11/16/202313:13EDGAR2Form SC 13G - Statement of acquisition of beneficial..
11/03/202307:36EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/03/202307:32EDGAR2Form 8-K - Current report
11/03/202307:30GLOBEArcutis Announces Third Quarter 2023 Financial Results and..
11/02/202316:00GLOBEArcutis Biotherapeutics Reports Inducement Grants Under..
10/25/202316:00GLOBEArcutis to Report Third Quarter 2023 Financial Results
10/23/202316:25EDGAR2Form 8-K - Current report
10/23/202316:23EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/20/202308:00GLOBENew Data Shows ZORYVE® (Roflumilast) Cream 0.3% Provided..
10/19/202323:45GLOBEArcutis Announces Pricing of $100 Million Public Offering
10/19/202316:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/19/202316:04GLOBEArcutis Announces Proposed Public Offering
10/19/202316:02EDGAR2Form 8-K - Current report
10/13/202308:00GLOBEArcutis Presents Positive Patient-Reported Outcome Data from..
10/06/202308:52DJNArcutis Biotherapeutics Shares Rise Premarket As FDA OKs..
10/06/202308:00GLOBEFDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for..
10/05/202316:00GLOBEArcutis Biotherapeutics Reports Inducement Grants Under..
10/03/202321:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/03/202321:41EDGAR2Form 3 - Initial statement of beneficial ownership of..
9/27/202316:30EDGAR2Form 8-K - Current report
9/27/202308:00GLOBEArcutis Appoints L. Todd Edwards as Chief Commercial Officer
9/25/202309:00GLOBENew Campaign from Arcutis Aims to Educate, Raise Awareness,..
9/19/202307:30GLOBEArcutis Announces Positive Results from INTEGUMENT-PED..
9/15/202316:09EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
9/15/202316:08EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
9/15/202316:07EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
9/15/202316:00GLOBEArcutis Biotherapeutics Reports Inducement Grants Under..
9/12/202307:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/12/202307:30GLOBEArcutis Submits Roflumilast Cream 0.15% Supplemental New..
9/07/202308:15GLOBEArcutis Announces Positive Long-Term Results of Roflumilast..
9/07/202306:48EDGAR2Form 8-K/A - Current report: [Amend]
9/05/202316:00GLOBEArcutis to Present at Upcoming Investor Conference
8/31/202308:00GLOBEArcutis Biotherapeutics Publishes Annual Environmental,..
8/29/202308:00GLOBEArcutis Launches First Television Ad for ZORYVE®..
8/18/202316:32EDGAR2Form 8-K - Current report
8/18/202316:30GLOBEArcutis Appoints Interim Chief Financial Officer (CFO)
8/15/202316:31EDGAR2Form 144 - Report of proposed sale of securities
8/14/202317:22EDGAR2Form 8-K - Current report
8/10/202308:16GLOBEArcutis and Huadong Announce Strategic Collaboration and..
8/08/202316:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/202316:04EDGAR2Form 8-K - Current report
8/08/202316:02GLOBEArcutis Announces Second Quarter 2023 Financial Results and..
8/04/202316:00GLOBEArcutis Biotherapeutics Reports Inducement Grants Under..
7/24/202316:00GLOBEArcutis to Report Second Quarter Financial Results

Your Recent History

NASDAQ
ARQT
Arcutis Biotherapeutics
Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com